Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.
about
Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularizationImmunotherapy and radiation therapy for malignant pleural mesothelioma.Terminal arteriolar network structure/function and plasma cytokine levels in db/db and ob/ob mouse skeletal muscle.Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.Antitumor activity of tumor-targeted RNA replicase-based plasmid that expresses interleukin-2 in a murine melanoma model.The significant role of mast cells in cancer.Tryptase expression as a prognostic marker in patients with resected gastric cancer.Increased frequency of circulating invariant natural killer T cells in malignant pleural mesothelioma patients.Combining immunotherapy with radiation therapy in thoracic oncology
P2860
Q28582445-160C34DD-8275-405D-B98E-8DE2F870DB75Q33645613-31A8E77A-691A-4474-AC86-BA20CAC9B496Q34842420-2EA51BA3-F512-4577-B3F8-BF73B1C3BF73Q35711576-98E43560-773D-4154-90D0-23F90C9C1610Q37065888-E65BE650-0CED-4456-8F90-82BE91D8E268Q37834484-FB8CB48C-10C8-4E31-B18C-DAA3B98D8981Q40186049-EEE4CC82-8355-41B5-A68C-527159C6C0B0Q46190547-09E9E00E-8135-425B-A92F-409F66B8C836Q58804834-0E40F68E-3374-414B-B061-B90DB373C20C
P2860
Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment with interleukin-2 i ...... essment and prognostic impact.
@en
Treatment with interleukin-2 i ...... essment and prognostic impact.
@nl
type
label
Treatment with interleukin-2 i ...... essment and prognostic impact.
@en
Treatment with interleukin-2 i ...... essment and prognostic impact.
@nl
prefLabel
Treatment with interleukin-2 i ...... essment and prognostic impact.
@en
Treatment with interleukin-2 i ...... essment and prognostic impact.
@nl
P2093
P2860
P50
P356
P1476
Treatment with interleukin-2 i ...... sessment and prognostic impact
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605438
P407
P577
2009-12-01T00:00:00Z